Cargando…

Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents

Detalles Bibliográficos
Autores principales:	Sharp, Michelle, Donnelly, Seamas C., Moller, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559733/ https://www.ncbi.nlm.nih.gov/pubmed/31187094 http://dx.doi.org/10.1016/j.yrmex.2019.100004

Ejemplares similares

Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
por: Russell, David J., et al.
Publicado: (2017)

TNF-α inhibitors used as steroid-sparing maintenance monotherapy in parenchymal CNS sarcoidosis
por: Hilezian, Frédéric, et al.
Publicado: (2021)

The Long-Term Use of Methotrexate Monotherapy as a Steroid-Sparing Agent for Patients With Pulmonary Sarcoidosis
por: Baiyasi, Ahmad F, et al.
Publicado: (2021)

Steroid-Sparing Effect of Tocilizumab and Methotrexate in Patients with Polymyalgia Rheumatica: A Retrospective Cohort Study
por: Izumi, Keisuke, et al.
Publicado: (2021)

Steroid-sparing agents for the treatment of inflammation in complicated neurocysticercosis
por: Anand, Pria, et al.
Publicado: (2019)

CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent
por: Thebault, Simon, et al.
Publicado: (2022)

Immunoglobulins as steroid sparing agents in chronic relapsing inflammatory optic neuropathy
por: Gonzalez-Granado, Luis I.
Publicado: (2010)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma
por: Bilocca, David, et al.
Publicado: (2017)

Treatment of immunoglobulin G4-related sialadenitis: outcomes of glucocorticoid therapy combined with steroid-sparing agents
por: Hong, Xia, et al.
Publicado: (2018)

Long‐Term Corticosteroid‐Sparing Immunosuppression for Cardiac Sarcoidosis
por: Rosenthal, David G., et al.
Publicado: (2019)

Psychological burden associated with worse clinical outcomes in sarcoidosis
por: Sharp, Michelle, et al.
Publicado: (2019)

TNF and anti-TNF agents in Behçet's disease
por: Calamia, KT
Publicado: (2003)

1406. Steroid-Sparing Agents to Control Inflammation in Complicated Neurocysticercosis: Three Cases
por: Anand, Pria, et al.
Publicado: (2019)

Tolosa–Hunt Syndrome: Long-Term Outcome and Role of Steroid-Sparing Agents
por: Arthur, Anupriya, et al.
Publicado: (2020)

Rituximab Can Induce Remission in a Patient with Ankylosing Spondylitis Who Failed Anti-TNF-α Agent
por: AlDhaheri, Fahmi, et al.
Publicado: (2017)

Anti-Inflammatory and General Glucocorticoid Physiology in Skeletal Muscles Affected by Duchenne Muscular Dystrophy: Exploration of Steroid-Sparing Agents
por: Herbelet, Sandrine, et al.
Publicado: (2020)

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2023)

Valve-sparing reoperations for failed pulmonary autografts
por: Goldstone, Andrew B., et al.
Publicado: (2021)

Sarcoidosis, steroids and Strongyloides—what's the catch?
por: Kumar, A., et al.
Publicado: (2020)

Case Report: TNFα Antagonists Are an Effective Therapy in Cardiac Sarcoidosis
por: Stievenart, Julien, et al.
Publicado: (2021)

Risk of failing both methotrexate and mycophenolate mofetil from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) uveitis trial
por: Reddy, Amit K., et al.
Publicado: (2023)

Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet's Disease, Sarcoidosis, and Noninfectious Uveitis
por: Sánchez-Cano, Daniel, et al.
Publicado: (2013)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

The Role of Hydroxychloroquine as a Steroid-sparing Agent in the Treatment of Immune Thrombocytopenia: A Review of the Literature
por: Mohammadpour, Fatemeh, et al.
Publicado: (2018)

Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
por: Zeng, Faith A.P., et al.
Publicado: (2022)

Bone-sparing effects of tocilizumab in rheumatoid arthritis: a monocentric observational study
por: Al Khayyat, Suhel Gabriele, et al.
Publicado: (2022)

Brainstem Infarction and Panuveitis due to Sarcoidosis Successfully Treated with Steroid Pulse Therapy
por: Yoshida-Hata, Natsuyo, et al.
Publicado: (2012)

Steroid pulse therapy was effective for cardiac sarcoidosis with ventricular tachycardia and systolic dysfunction
por: Okabe, Toshitaka, et al.
Publicado: (2016)

Transmembrane TNF-α: structure, function and interaction with anti-TNF agents
por: Horiuchi, Takahiko, et al.
Publicado: (2010)

Bevacizumab as a steroid‐sparing agent during immunotherapy for melanoma brain metastases: A case series
por: Banks, Patricia D., et al.
Publicado: (2019)

A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
por: Heckmann, Jeannine M, et al.
Publicado: (2011)

Steroids Decrease Prevalence of Positive Tuberculin Skin Test in Rheumatoid Arthritis: Implications on Anti-TNF Therapies
por: Agarwal, Shweta, et al.
Publicado: (2014)

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients
por: Toda, Masataro, et al.
Publicado: (2021)

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
por: Finckh, A, et al.
Publicado: (2010)

High levels of TNFα in patients with COVID-19 refractory to tocilizumab
por: Danlos, F.X., et al.
Publicado: (2021)

Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury
por: SARIOĞLU, Nurhan, et al.
Publicado: (2021)

A case of Tocilizumab-induced thrombocytopenia in steroid-resistant Graves orbitopathy
por: Cuculescu, Victoria, et al.
Publicado: (2023)

Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry
por: Sweiss, Nadera J., et al.
Publicado: (2011)

A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis
por: Di, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a5i8k04f73c6604t2adrqlnivt